INTRODUCTION
============

Melanin, a naturally synthesized pigment in melanocytes, is stored inside the melanosome, which determines the color of human skin, hair, and eyes \[[@B1]\]. Melanin is originally produced to protect skin from ultraviolet (UV) radiation, however, overproduction and accumulation can cause various dermatological disorders such as melanoma, freckles, age spots, and other hyperpigmentation syndromes \[[@B2],[@B3]\]. Melanogenesis is a complicated pathway made up of melanin synthesis, melanin transport, and melanosome release \[[@B4]\]. This cascade of melanogenesis is stimulated by a variety of environmental biochemical factors, α-melanocyte stimulating hormone (α-MSH), cyclic AMP (cAMP) elevating agents, including forskolin, glycyrrhizin, isobutylmethylxanthine, and UVB exposure \[[@B5],[@B6],[@B7],[@B8],[@B9]\]. Among them, α-MSH, a naturally occurring melanotropic peptide, has been used as a melanogenesis inducer in many studies \[[@B10],[@B11],[@B12]\].

Enzymatic reaction for melanogenesis is associated with tyrosinase, TRP-1 (dopachrome tautomerase), and TRP-2 (DHICA oxidase) \[[@B10],[@B13]\]. Tyrosinase, the critical and rate-limiting enzyme involved in the first two-step reaction of melanogenesis, hydroxylates tyrosine to 3,4-dihydroxyphenylalanine (L-DOPA) and the subsequent oxidation of L-DOPA to dopaquinone. Dopaquinone is auto-oxidized into dopachrome, which is converted to dihyroxyindole (DHI) or dihydroxyindole-2-carboxylic acid (DHICA) for production of black eumelanins, whereas similar reactions related to cysteine and glutathione conjugates of dopaquinone yield reddish-brown pheomelanins \[[@B14]\]. In addition, hydrogen peroxide (H~2~O~2~) and other reactive oxygen species (ROS) are synthesized during melanogenesis, which functions to enhance pigment formation by regulating levels of tyrosine \[[@B15]\]. Therefore, development of an effective tyrosinase inhibitor with antioxidative capacity can be a promising strategy for a potential anti-melanogenic agent.

*Vitis amurensis* Ruprecht, a species of grape native to Asian countries, exhibited various biological activities, including antioxidative \[[@B16],[@B17],[@B18]\], neuroprotective \[[@B19],[@B20],[@B21]\], anti-tumorogenic \[[@B22],[@B23]\], antimicrobial \[[@B24]\], and anti-inflammatory activities \[[@B25],[@B26]\]. Hence, many researchers have attempted to identify its functional compounds, which were proved as phenolic compounds \[[@B17],[@B27]\], procyanidin \[[@B28]\], oligostilbenes such as amurensin A, B, and G \[[@B29],[@B30]\], and stilbenes such as resveratrol and its tetramer, heyneanol A \[[@B19],[@B22]\]. In addition, root of *V. amurensis* has also been used as a medicinal herb in oriental medicine. Although root of *V. amurensis* has been reported to possess anti-tumorigenic \[[@B22],[@B31]\] and anti-inflammatory activity \[[@B32]\], no investigation of anti-melanogenic activity has been reported.

The aim of the current study is to investigate anti-oxidative and anti-melanogenic effects of *V. amurensis* Ruprecht root methanol extract (VARM) in B16F10 cells, and then identify its functional compounds among various solvent fractions.

MATERIALS AND METHODS
=====================

Reagents
--------

1,1-diphenyl-2-picryl hydrazyl (DPPH), mushroom tyrosinase, α-MSH, L-DOPA, and betulinic acid were purchased from Sigma (St. Louis, MO, USA). Dulbecco\'s modified Eagle medium (DMEM), fetal bovine serum (FBS), and L-glutamine were obtained from Invitrogen Corporation (Carlsbad, CA, USA). Antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) for tyrosinase, actin, and secondary antibodies. Nitrocellulose membrane was purchased from GE Healthcare (Little Chalfont, Buckinghamshire, UK). All other chemicals were of the highest commercial grade available.

Preparation of VARM and its solvent fractions
---------------------------------------------

*V. amurensis* Ruprecht root, which was purchased from Daehan Natural Drug (Busan, Republic of Korea), originated from Yeong cheon in Korea. Dried powder of *V. amurensis* Ruprecht root (5 kg) was extracted four times with five volumes of absolute (99.8%) methanol at 65℃. The extract was evaporated, freeze dried, and stored at 4℃ until use. Methanol extract of *V. amurensis* Ruprecht root (VARM, 527.6 g) was suspended in water and serially fractionated into dichloromethane (CH~2~Cl~2~, C fraction, 21.3 g), ethyl acetate (EtOAc, E fraction, 81.1 g), *n*-butanol (*n*-BuOH, B fraction, 71.3 g), and water (H~2~O, W fraction, 246.1 g). The C fraction, which exhibited potent anti-melanogenic activity without cytotoxicity, was applied onto a silica gel (70-230 mesh, Merk, Darmstadt, Germany) column. The column was eluted using mixtures of n-hexane:EtOAc under gradient conditions \[10:1, 5:1, 3:1, 2:1, 1:1 (v/v)\] to yield the four fractions (fraction 1 to 4). Among four fractions, fraction 3 was further purified by a silica gel once more to yield six fractions (fraction 1 to 6). Among them, fraction 3 was identified as a betulinic acid through ^1^H nuclear magnetic resonance (NMR) and ^13^C-NMR analyses. For identification of betulinic acid, TLC was performed on a precoated Merck Kieselgel 60 F~254~ plate (0.25 mm) and the spots were compared with standard betulinic acid purchased from Sigma.

DPPH radical scavenging activity assay
--------------------------------------

Antioxidative activity of VARM and its solvent fractions were determined using a DPPH radical scavenging assay as described previously \[[@B33]\]. Various concentrations of reagents and standard compound (Ascorbic acid) were added to DPPH solution. Absorbance was measured at 520 nm after 30 min incubation protected from light.

Mushroom tyrosinase inhibition assay
------------------------------------

The effect of VARM on mushroom tyrosinase activity was determined as previously described \[[@B34]\]. In brief, 50 µL of mushroom tyrosinase (700 unit/mL), 50 µL of various concentrations of reagents, and 100 µL of 0.1 M phosphate buffer (pH 6.8) were added to a 96-well plate and mixed, 100 µL of 2.5 mM~L~-DOPA was added, followed by incubation for 20 min at room temperature. The amount of dopachrome formed in the reaction mixture was measured at 475 nm. Kojic acid was used as a positive control.

Cell culture and treatment
--------------------------

B16F10 murine melanoma cells (CRL-6475) were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were maintained in DMEM supplemented with 10% FBS and 100 units/mL of penicillin/streptomycin at 37℃ in a humidified atmosphere containing 5% CO~2~. Cells were treated with either α-MSH alone or reagents together. Cells not treated with α-MSH served as the negative control, while cells treated with α-MSH alone served as the positive control.

Cell viability assay
--------------------

Cell viability was determined using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay purchased from Daeil Lab Service (Seoul, Korea) according to the manufacturer\'s instructions \[[@B35]\]. After treatment with various concentrations of VARM and its solvent fractions, cells were incubated with MTS for 1 h and the viability was quantified by measurement at OD~450~ using a multi-plate reader (Paradigm, Beckman, CA, USA).

Cellular melanin contents
-------------------------

Effect of VARM and its solvent fractions on α-MSH induced melanogenesis on B16F10 cells was investigated according to the previous research, which was slightly modified \[[@B36]\]. Briefly, cells were stimulated with α-MSH (200 nM) and treated with VARM and its solvent fractions for 72 hr. After treatment, the cells were dissolved in 1 N NaOH/10% DMSO for 1 hr at 80℃, and solubilized melanin was measured at 475 nm.

Intracellular tyrosinase activity
---------------------------------

Effect of VARM and its solvent fractions on α-MSH induced tyrosinase activity on B16F10 cells was investigated according to the previous research, which was slightly modified \[[@B36]\]. Briefly, cells were stimulated with α-MSH (200 nM) and treated with VARM and its solvent fractions for 72 hr. After treatment, the cells were washed with 1 × phosphate buffered saline (PBS), and then lysed into protein lysis buffer (Cell Signaling Technology, Boston, MA, USA). Each extract was placed in each well of a 96-well plate and the enzymatic assay was commenced by addition of L-DOPA. After incubation, dopachrome formation was assayed by measuring absorbance at 475 nm.

Western blot hybridization
--------------------------

After treatment, the cells were washed with ice-cold 1 × PBS and lysed with cell lysis buffer (pH 7.4). The cell lysates were incubated on ice for 30 min and the homogenates were centrifuged at 13,000 × g for 10 min at 4℃. The supernatants were collected and protein concentration was determined using the Bradford protein assay. Protein samples (50 µg) were mixed with 2 × loading buffer, and boiled at 100℃ for 5 min. The samples were separated on a 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel and electrotransferred to nitrocellulose membranes (Whatman*TM*, GE Healthcare, Little Chalfont, UK). The membranes were blocked with 5% nonfat dry milk in 1 × PBST buffer (0.1% Tween 20 in PBS) for 1 hr at room temperature and incubated overnight with primary antibodies in blocking buffer at 4℃. The membranes were washed, followed by incubation with anti-rabbit-IgG or anti-goat-IgG with horseradish peroxidase for 1 hr at room temperature. After washing the membrane, final detection and quantification were performed using a chemiluminescence detection system (FluoChem® FC2, Alpha Innotech, CA, USA).

Statistical analysis
--------------------

The data were expressed as mean ± standard deviation (SD). The values were compared to the control using analysis of variance (ANOVA) followed by unpaired Student\'s *t*-tests. A *P* value \< 0.05 was considered significant.

RESULTS
=======

VARM scavenged DPPH free radical and tyrosinase activity
--------------------------------------------------------

Thus far, a potent DPPH scavenger among natural resources has been regarded as a potential antioxidant candidate. In this study, VARM was evaluated for its anti-oxidative activity by DPPH, a stable free radical, scavenging capacity. As shown in [Fig. 1A](#F1){ref-type="fig"}, VARM scavenged free radicals in a dose dependent manner, with an inhibitory rate of 15.6, 50.2, and 95.8% at 2.56, 12.8, and 64 µg/mL, respectively. Dose for IC~50~ was calculated as 12.8 µg/mL. As shown in [Fig. 1B](#F1){ref-type="fig"}, VARM suppressed the enzyme activity of mushroom tyrosinase, with an inhibitory rate of 6.7, 46.0, and 87.9% at 20, 100, and 500 µg/mL, respectively. The IC~50~ value was calculated as 148.1 µg/mL. IC~50~ values of DPPH radical scavenging and tyrosinase inhibitory activity issued from VARM-treated B16F10 cells are shown in [Table 1](#T1){ref-type="table"}.

VARM inhibited α-MSH induced melanogenesis without cytotoxicity
---------------------------------------------------------------

The cytotoxicity of VARM for 48 hr was determined using a colorimetric MTS assay in B16F10 cells. [Fig. 2A](#F2){ref-type="fig"} shows the percent cell viability of VARM-treated cells compared with that of vehicle treated cells. No remarkable cytotoxicity was observed in cells treated with VARM under the concentration of 200 µg/mL, which was applied for the following cascade of experiments. As shown in [Fig. 2B](#F2){ref-type="fig"}, melanin content of α-MSH stimulated cells was 2.5 times higher than that of vehicle treated cells, indicating that melanogenesis was successfully induced by α-MSH treatment. On the other hand, α-MSH-stimulated melanin production was significantly (*P* \< 0.5) inhibited by treatment with VARM in a dose-dependent manner ([Fig. 2B](#F2){ref-type="fig"}).

C fraction from VARM exhibited the most potent anti-melanogenic activity induced by α-MSH
-----------------------------------------------------------------------------------------

VARM was serially fractionated with CH~2~Cl~2~, EtOAc, *n*-BuOH, and H~2~O for identification of active compounds possessing anti-melanogenic activity ([Fig. 3](#F3){ref-type="fig"}). The effect of each fraction on B16F10 cell viability was evaluated in advance of the downstream experiment. As shown in [Fig. 4A](#F4){ref-type="fig"}, VARM, C, and B fractions did not show any cytotoxicity below 250 µg/mL, while the E fraction exhibited a cytotoxic effect over 50 µg/mL. Followed by the result for cell viability, anti-melanogenic effect of each fraction was evaluated on non-cytotoxic doses. As shown in [Fig. 4B](#F4){ref-type="fig"}, the C fraction induced the most potent inhibition of α-MSH induced melanogenesis among all fractions that exhibited an anti-melanogenic effect. In the W fraction, neither cytotoxic nor anti-melanogenic activities were detected.

VARM and its solvent fractions inhibited cellular tyrosinase activity
---------------------------------------------------------------------

To confirm the anti-melanogenic effect of VARM and its solvent fractions, cellular tyrosinase enzymatic activity and protein expression level were analyzed. As shown in [Fig. 5A](#F5){ref-type="fig"}, elevated tyrosinase enzyme activity induced by α-MSH was down-regulated by VARM and its solvent fractions, including C, E, and B. In addition, tyrosinase protein expression was also inhibited by VARM and its solvent fractions, which was in accordance with melanin contents and tyrosinase activity ([Fig. 5B](#F5){ref-type="fig"}). According to the results, anti-melanogenic effects of VARM and its solvent fractions originated from the inhibited tyrosinase activity. Among all fractions of VARM, the C fraction showed the most potent anti-melanogenic activity without cytotoxicity ([Fig. 6A](#F6){ref-type="fig"}).

Betulinic acid originating from the C fraction exhibited potent anti-melanogenic activity
-----------------------------------------------------------------------------------------

Identification and purification of the functional compounds contained in the C fraction, which showed the most potent anti-melanogenic activity, was attempted. As a result, various compounds were identified as methyl palmitate, palmitate, methyl stearate, oleanolic acid, and betulinic acid. Among them, only betulinic acid significantly attenuated α-MSH-induced melanogenesis in a dose dependent manner, which was stronger than that of arbutin, a well-known depigmenting agent ([Fig. 6B](#F6){ref-type="fig"}).

DISCUSSION
==========

Appropriate melanogenesis provides an effective protection mechanism against harmful ultraviolet radiation; however, abnormal production of melanin and accumulation lead to various dermatological disorders. Therefore, many scientists have attempted to find new agents to alleviate hyperpigmentation and melanin accumulation. In this study, anti-melanogenic activity of *V. amurensis* Reprecht root was evaluated through analysis of tyrosinase and melanin content in α-MSH stimulated B16F10 cells. In addition, isolation and identification of the active compound possessing anti-melanogenic activity in *V. amurensis* Reprecht root was attempted.

During melanogenesis stimulatory cascade, α-MSH is an important component in both human melanocytes and murine melanoma cells \[[@B37]\]. Melanocortin 1 receptor (MC1R) bound to α-MSH regulates melanocytic pigmentation through modulation of G protein-coupled receptor (GPCR)-cAMP-microphthalmia-associated transcription factor (MITF) signaling cascade. Once MITF was activated, downstream target genes including TRP-1 and 2, which play crucial role in melanogenesis, were activated serially \[[@B38]\]. Results of the current study indicate that α-MSH-initiated melanin synthesis was abolished by treatment with VARM and its solvent fractions, suggesting that *V. amurensis* Reprecht root possesses the potential to disrupt melanin production cascade in melanocytes.

Because tyrosinase is a rate-limiting enzyme related to the first two steps of melanogenesis, agents possessing tyrosinase inhibitory activity can be regarded as potential candidates for a depigmentation strategy \[[@B39]\]. Therefore, tyrosinase activity was analyzed for evaluation of the involved mechanisms of VARM and its solvent fractions-induced antimelanogenesis in B16F10 cells. In this study, two kinds of tyrosinases were investigated; an intracellular tyrosinase and a mushroom tyrosinase. Intracellular tyrosinase activity was analyzed by measurement of generated dopachrome in α-MSH stimulated B16F10 cells. Treatment with VARM and its solvent fractions resulted in significantly attenuated intracellular tyrosinase activity as evidenced by a decrease in the quantity of dopachrome. Mushroom tyrosinase activity was also analyzed to determine whether VARM and its solvent fractions-induced intracellular tyrosinase inhibitory effect originated directly from inhibited enzyme activity or disruption the enzyme synthesis pathway. In accordance with the result of intracellular tyrosinase assay, VARM and its solvent fractions attenuated dopachrome formation through modulation of mushroom tyrosinase activity, indicating direct inhibition of tyrosinase activity by VARM.

When the skin is exposed to UV radiation and other environmental oxidizing pollutants, largely generated ROS and reactive nitrogen species (RNS) can induce lipid peroxidation and enzyme inactivation in cutaneous tissue. Therefore, antioxidative compounds that can counteract oxidative damage have been considered as beneficial agents for skin. For example, oligomeric proanthocyanidins from grape seeds effectively inhibit UV-induced oxidative stress considered to promote melanogenesis \[[@B40]\]. VARM and its solvent fractions-induced melanin decrease may be attributed to its depletion of ROS and RNS.

These results suggest that *V. amurensis* Reprecht root possesses antimelanogenic activity by regulation of cellular tyrosinase activity in melanocytes. Therefore, an active compound contained in *V. amurensis* Reprecht root was isolated and confirmed as betulinic acid. Betulinic acid is a naturally occurring pentacyclic triterpenoid found in the bark of several species of plants \[[@B41]\]. Although various biological activities, including anti-inflammatory, antibacterial, and anticarcinogenic activities from various plants have been reported for betulinic acid, this is the first finding that not only does betulinic acid originate from *V. amurensis* Ruprecht root it also possesses anti-melanogenic activity \[[@B41],[@B42],[@B43],[@B44]\]. Although melanogenesis inhibitory compounds were also found from *Saussureae Radix*, that was not betulinic acid but betulinic acid methyl ester. Furthermore that compound showed lower activity than arbutin used as a positive control \[[@B45]\].

In this study, anti-oxidative and anti-melanogenic activities of VARM and its solvent fractions were evaluated. VARM and all fractions possessed potent anti-melanogenic activities originating from the direct inhibition of cellular tyrosinase activity, which mainly originated from the active compound, betulinic acid. These results suggest that *V. amurensis* Ruprecht root and betulinic acid may be utilized as potential depigmenting agents by modulation of tyrosinase activity in melanocytes.
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![**DPPH radical scavenging activity (A) and tyrosinase inhibition activity (B) of VARM.** Ascorbic acid (C) and Kojic acid (D) are used as positive controls for DPPH radical scavenging activity and tyrosinase inhibition activity, respectively.](nrp-8-509-g001){#F1}

![**Effect of VARM on B16F10 cell viability (A) and α-MSH induced melanogenesis (B).** Arbutin is used as a positive control. Values are expressed as mean ± SD (*n* = 3). ^\*^, ^\*\*^ Significantly different from the vehicle treated control and α-MSH treated control, respectively (*P* \< 0.05).](nrp-8-509-g002){#F2}

![Scheme of the preparation and isolation of VARM, its solvent fractions, and active compounds originated from the C fraction of VARM](nrp-8-509-g003){#F3}

![**Effect of VARM and its solvent fractions on B16F10 cell viability (A) and α-MSH induced melanogenesis (B).** M, VARM; C, CH~2~Cl~2~ fraction; E, EtOAc fraction; B, BuOH fraction; W, H~2~O fraction. Arbutin is used as a positive control. ^\*^, ^\*\*^Significantly different from the vehicle treated control and α-MSH treated control, respectively (*P* \< 0.05).](nrp-8-509-g004){#F4}

![**Effect of VARM and its solvent fractions on cellular tyrosinase activity (A) and tyrosinase protein expression (B).** M, VARM; C, CH~2~Cl~2~ fraction; E, EtOAc fraction; B, BuOH fraction; A, arbutin used as a positive control. ^\*^, ^\*\*^Significantly different from the vehicle treated control and α-MSH treated control, respectively (*P* \< 0.05).](nrp-8-509-g005){#F5}

![**Anti-melanogenic activity of the C fraction (A) and betulinic acid originated from the C fraction (B) of VARM.** Arbutin is used as a positive control. ^\*^, ^\*\*^Significantly different from the vehicle treated control and α-MSH treated control, respectively (*P* \< 0.05).](nrp-8-509-g006){#F6}
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IC~50~ of DPPH radical scavenging activity and tyrosinase inhibition activity of VARM

![](nrp-8-509-i001)

^\*^ Ascorbic acid is used as a positive control for DPPH radical scavenging activity assay.

^\*\*^ Kojic acid is used as a positive control for tyrosinase inhibition activity assay.

^\*\*\*^ N/A; not applicable
